You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A 48 year old woman was admitted with a history of weakness for two months. On examination, cervical lymph nodes were found enlarged and spleen was palpable 2 cm ptatelet count 237 X 109L and total leukocyte count 40 x coarse clumped chromatin. Bone marrow revelaed a nodular lymphoid infiltrate. The peripheral blood lymphoid were negative for CD 19. CD5, CD 20 and CD 23 and were negative for CD 79 B and FMC - 7. What is the most likely diagnosis? and explain in detail?
Answer is B (Chronic Lymphocytic Leukemia) Coexpression of the B Lymphocyte lineage marker CD 19 and the T lymphocyte marker CD 5 is unique to CLL and Mantle cell Lymphoma. 10cm)/progressive lymphadenopathy * Massive (>6cm)/progressive splenomegaly * Progressive lymphocytosis (doubling time <6 months) * Systemic symptoms; * Weight loss >10%in 6 months fever>38deg C for >2 weeks extreme fatigue or night sweats * Autoimmune cytopenias (this may only require treatment of the autoimmune component not necessarily the leukaemia) " align="left" height="155" width="528">CD 23 is expressed by CLL and not by Mantle cell Lymphomas. CLL cells are also negative for CD 79B and FM 7 and hence CLL is the answer of choice. CDS CD9 CD23 Mantle cell Lymphoma ++ ++ +-/+ CLL ++ ++ ++ Mantle cell Lymphoma also tend to express higher levels of CD79a and CD79b than CLL.